Outcomes of Hodgkin lymphoma patients who relapse after allogeneic stem cell transplantation

被引：2
|
作者：
Castagna, L. [1 ]
Sarina, B. [1 ,8 ]
Crocchiolo, R. [1 ,4 ]
Bramanti, S. [4 ,5 ,7 ]
Furst, S. [3 ,4 ,6 ,8 ]
Devillier, R. [2 ,4 ,5 ,7 ]
Coso, D. [2 ,9 ]
Bouabdallah, R. [3 ,5 ]
Mokart, D. [6 ,8 ]
Morabito, L. [6 ]
Harbi, S. [2 ,8 ,9 ]
Giordano, L. [7 ]
Rimondo, A.
Weiller, P. Jean
Carlo-Stella, C. [9 ]
Santoro, A. [3 ]
Chabannon, C.
Blaise, D.
机构：
[1] Dept Hematol, Transplantat Program, Humanitas Canc Ctr, Humanitas Clin & Res Ctr, Rozzano, Italy
[2] Dept Hematol, Lymphoma Program, Humanitas Canc Ctr, Humanitas Clin & Res Ctr, Rozzano, Italy
[3] Inst Paoli Calmettes, Intens Care Unit, Marseille, France
[4] Biostatist Unit, Humanitas Canc Ctr, Humanitas Clin & Res Ctr, Rozzano, Italy
[5] Univ Milan, Dept Med Biotechnol & Translat Med, Milan, Italy
[6] Humanitas Univ, Rozzano, Italy
[7] Inst Paoli Calmettes, Cell Therapy Unit, Marseille, France
[8] Aix Marseille Univ, Marseille, France
[9] Aix Marseille Univ, Inst Paoli Calmettes, Ctr Rech Cancerol Marseille, INSERM, Marseille, France
来源：
BONE MARROW TRANSPLANTATION | 2016年 / 51卷 / 12期
关键词：
BRENTUXIMAB VEDOTIN;
D O I：
10.1038/bmt.2016.257
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：1644 / 1646
页数：3
相关论文
共 50 条
  • [31] Outcomes of Patients With Classic Hodgkin Lymphoma Who Relapsed After Autologous Stem Cell Transplant
    Tun, Aung M.
    Wang, Yucai
    Matin, Aasiya
    Inwards, David J.
    Habermann, Thomas M.
    Micallef, Ivana
    Johnston, Patrick B.
    Porrata, Luis
    Paludo, Jonas
    Bisneto, Jose Villasboas
    Rosenthal, Allison
    Tun, Han W.
    Cerhan, James R.
    Witzig, Thomas E.
    Nowakowski, Grzegorz S.
    Ansell, Stephen M.
    HEMASPHERE, 2023, 7 (04): : E869
  • [32] Outcomes of Allogeneic Stem Cell Transplant in Patients with Relapsed/Refractory Hodgkin Lymphoma
    Ge, Shiliang
    Lepic, Kylie
    Bhindi, Ravi
    Berg, Tobias
    Khalaf, Dina
    Leber, Brian
    Radford, Michael
    Walker, Irwin
    Davies, Gwynivere
    Garcia-Horton, Alejandro
    CURRENT ONCOLOGY, 2025, 32 (02)
  • [33] Autologous and allogeneic stem cell transplantation in Hodgkin's lymphoma
    Sureda, Anna
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2007, 21 (05) : 943 - +
  • [34] Allogeneic Stem Cell Transplantation for Non-Hodgkin Lymphoma
    Bhatt, Vijaya Raj
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2016, 11 (03) : 196 - 207
  • [35] The Role of Allogeneic Stem Cell Transplantation in Hodgkin’s Lymphoma
    Anna Sureda
    E. Domenech
    N. Schmitz
    P. Dreger
    Current Treatment Options in Oncology, 2014, 15 : 238 - 247
  • [36] Allogeneic Stem Cell Transplantation for Non-Hodgkin Lymphoma
    Vijaya Raj Bhatt
    Current Hematologic Malignancy Reports, 2016, 11 : 196 - 207
  • [37] The Role of Allogeneic Stem Cell Transplantation in Hodgkin's Lymphoma
    Sureda, Anna
    Domenech, E.
    Schmitz, N.
    Dreger, P.
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2014, 15 (02) : 238 - 247
  • [38] Brentuximab vedotin for relapse or progression therapy after allogeneic hematopoietic stem cell transplantation in relapsed / refractory classic Hodgkin lymphoma
    Mikhailova, N.
    Popova, M.
    Kondakova, E.
    Ivanova, M.
    Borzenkova, E.
    Alaynskiy, A.
    Bondarenko, S.
    Afanasyev, B.
    Babenko, E.
    BONE MARROW TRANSPLANTATION, 2016, 51 : S503 - S503
  • [39] ALLOGENEIC STEM CELL TRANSPLANTATION FOR POST-AUTOLOGOUS STEM CELL TRANSPLANT RELAPSE IN HODGKIN LYMPHOMA: EXPERIENCE AT A SINGLE CENTER
    Oliva, J. L.
    Kelly, J. L.
    Liesveld, J. L.
    Becker, M. W.
    Phillips, G. L.
    Sensenig, E.
    Constine, L.
    Bernstein, S. H.
    Fisher, R., I
    Friedberg, J. W.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2008, 14 (02) : 66 - 66
  • [40] Nivolumab salvage therapy before or after allogeneic stem cell transplantation in Hodgkin lymphoma
    El Cheikh, J.
    Massoud, R.
    Abudalle, I.
    Haffar, B.
    Mahfouz, R.
    Kharfan-Dabaja, M. A.
    Jisr, T.
    Mougharbel, A.
    Ibrahim, A.
    Bazarbachi, A.
    BONE MARROW TRANSPLANTATION, 2017, 52 (07) : 1074 - 1077
12345